The clinical use of HVPG measurements in chronic liver disease
- 1 September 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Gastroenterology & Hepatology
- Vol. 6 (10), 573-582
- https://doi.org/10.1038/nrgastro.2009.149
Abstract
Portal hypertension is a severe, almost unavoidable complication of chronic liver diseases and is responsible for the main clinical consequences of cirrhosis. Measurement of the hepatic venous pressure gradient (HVPG) is currently the best available method to evaluate the presence and severity of portal hypertension. Clinically significant portal hypertension is defined as an increase in HVPG to >or=10 mmHg; above this threshold, the complications of portal hypertension might begin to appear. Measurement of HVPG is increasingly used in clinical hepatology, and numerous studies have demonstrated that the parameter is a robust surrogate marker for hard clinical end points. The main clinical applications for HVPG include diagnosis, risk stratification, identification of patients with hepatocellular carcinoma who are candidates for liver resection, monitoring of the efficacy of medical treatment, and assessment of progression of portal hypertension. Patients who experience a reduction in HVPG of >or=20% or to <12 mmHg in response to drug therapy are defined as 'responders'. Responders have a markedly decreased risk of bleeding (or rebleeding), ascites, and spontaneous bacterial peritonitis, which results in improved survival.Keywords
This publication has 65 references indexed in Scilit:
- Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virusLiver International, 2008
- Portal hypertension and variceal bleeding-Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conferenceJournal of Hepatology, 2008
- Portal Hypertension and Gastrointestinal BleedingSeminars in Liver Disease, 2008
- Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled StudyGastroenterology, 2007
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2006
- Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitisJournal of Hepatology, 2005
- Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2005
- Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosisJournal of Hepatology, 2004
- Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosisJournal of Hepatology, 1988
- Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosisDigestive Diseases and Sciences, 1987